Pfizer, Gates Foundation team up on low-cost injectable contraceptive

Pfizer ($PFE) inked a deal with the Bill & Melinda Gates Foundation to roll out a long-acting contraceptive in 69 of the world's poorest countries. The drug is a version of its injectable Depo-Provera, packaged in capsule syringes for easy transport and injection. The product will be sold for about $1 per dose, subsidized by the foundation and the U.S. government. Report (sub. req.)

Suggested Articles

The CD19 antibody, used in tandem with Celgene's Revlimid, represents the first FDA approval in second-line diffuse large B-cell lymphoma.

Sanofi has faced a probe into birth defects tied to seizure med Depakine for years. Now, the investigation is moving forward on manslaughter charges.

Pfizer launched a multichannel awareness campaign centered on a first-ever radio station dedicated solely to metastatic breast cancer.